Published in Cancer Weekly, February 16th, 1998
M. Horimoto, representing colleagues from the Osaka University School of Medicine, Japan, presented the team's latest research at the 48th Annual Meeting of the American Association for the Study of Liver Diseases, held November 7-11, 1997 in Chicago, Illinois (abstract "New Therapeutic Approach against Human HCC by p21WAF1 Gene Transfer Combined with Anti-Cancer Agents").
"p21WAF1/CIP1/SDl1 (WAF1) is a G1 cyclin-dependent kinase inhibitor and acts as a growth suppressor,"...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.